Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Global Health Ltd. Share Price
Day's Range
Day's Range
Low
₹1,261.00
High
₹1,278.40
Price Summary
| Previous Close | ₹1,274.40 |
|---|---|
| Day's Range | ₹1,261.00 - ₹1,278.40 |
| Open | ₹1,265.80 |
| 52 Week Range | ₹956.00 - ₹1,456.50 |
| Volume | 97,371 |
| Market Cap | ₹0.03 |
| Previous Close | ₹1,272.45 |
|---|---|
| Day's Range | ₹1,262.00 - ₹1,284.15 |
| Open | ₹1,284.15 |
| 52 Week Range | ₹955.20 - ₹1,455.85 |
| Volume | 2,504 |
| Market Cap | ₹0.03 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,240.90 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 61.09 |
| TTM EPS (₹) | 20.70 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 8.56 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
| Trade Value ( ₹ in Lacs) | 31.86 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 61.09 |
| TTM EPS (₹) | 20.70 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 8.56 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 8028.68 | 32041.46 |
| Expenses | N/A | N/A |
| PBT | 1258.87 | 6230.47 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 934.12 | 4615.28 |
About Global Health Ltd.
| Founded | 2004 |
|---|---|
| Managing Director | Naresh Trehan |
| NSE Symbol | MEDANTA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,793.82 | 1,849.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,956.35 | 6,735.90 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,819.64 | 4,440.30 | 3,140.10 - 3,140.10 |
| Apollo Hospitals Enterprise Ltd. | 1,22,170.95 | 8,440.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,09,370.14 | 1,406.95 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,07,536.52 | 2,350.05 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 1,06,822.69 | 1,066.10 | 835.50 - 835.50 |
| Max Healthcare Institute Ltd. | 1,06,672.39 | 1,079.90 | 903.00 - 903.00 |
| Dr. Reddy's Laboratories Ltd. | 1,06,133.20 | 1,290.50 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 99,835.58 | 2,454.95 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Global Health informs about analyst meet
Global Health informs about updates
Ipca Laboratories informs about trading window closure
Aurobindo Pharma informs about press release
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of approval by Aurobindo Pharma USA, Inc. (‘Aurobindo USA’), a wholly owned subsidiary of the Company from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC (‘Lannett’).
The above information is a part of company’s filings submitted to BSE.
Dr Reddys Laboratories informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Global Health Ltd. is ₹1,274.40 as of 2026-06-22.
The market capitalisation of Global Health Ltd. is ₹33,992.95 as of 2026-06-19.
The 1-year return of Global Health Ltd. is 8.60% as of 2026-06-22.
The P/E ratio of Global Health Ltd. is 66.85 as of 2026-06-22.
The 52-week high and low of Global Health Ltd. are ₹1,456.50 and ₹956.00, respectively, as of 2026-06-22.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
